Target intelligence / Profile preview

Heat shock protein family B member 3 (HSPB3)

Target
HSPB3
Molecular classification
Small heat shock protein (sHsp), Molecular chaperone, Other
01

Overview

Heat shock protein family B member 3 (HSPB3) is a small heat shock protein primarily expressed in skeletal and cardiac muscle but also found in smooth muscle and the nervous system[3]. It acts as a molecular chaperone with moderate activity and is particularly important for muscle cell differentiation by regulating nuclear events and maintaining dynamic states of the lamin B receptor (LBR) and associated chromatin structure[1]. HSPB3 functions by binding to specific substrates and prevents their aggregation under cellular stress, thus supporting proteostasis and cytoskeletal integrity[2][3]. It forms oligomeric complexes (such as trimers and tetramers, and hetero-oligomers with HSPB2) and is developmentally regulated, especially upregulated during myoblast differentiation and in response to proteotoxic stress rather than heat shock[1][2][3]. Pathogenic mutations in HSPB3 are associated with neuromuscular diseases manifesting as impaired muscle differentiation, myopathies, and axonal motor neuropathies due to dominant-negative effects and misregulation of nuclear protein quality control[1][3]. *Note: No drugs directly targeting HSPB3, mechanisms of action for inhibitors/modulators, or established biomarker/safety use were found in the supplied literature as of this search. The protein is a specialized chaperone rather than a classic receptor, enzyme, or transporter drug target.*

Other names
Heat shock protein beta-3HSP27HSPL27HspB3HSP 17Heat shock 17 kDa proteinProtein 3DHMN2CHMN2CHMND4heat shock protein beta-3heat shock 27kDa protein 3
02

Biological functions

Protein folding (molecular chaperone activity)Muscle cell differentiation (myogenesis)Maintenance of proteostasisStructural maintenance of cytoskeletonRegulation of nuclear envelope protein dynamicsPrevention of protein aggregation
03

Disease associations

Neuromuscular disease (e.g., distal hereditary motor neuropathy, congenital myopathy)Muscular disordersPotential roles in neurodegenerative processesPossibly cancer and laminopathies via association with nuclear envelope regulation[1][3]
04

Safety considerations

Mutations linked to dominant-negative effects in muscle, causing nuclear protein aggregation and altered chromatin structureDisease mutations can lead to failure of muscle differentiation and activation of the unfolded protein response[1]

Beyond the preview

Go deeper on Heat shock protein family B member 3 (HSPB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein family B member 3 (HSPB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call